The IO drugs out now are what matter. Medi has redundancies. The majority of which won't even make it to phase II clinical trials. The poster below sounds like they are from AZ trying to keep spirits up. The IO race is now setting up the next 25 years and AZ has lost. You need money to fund trials. Durvalumab will be lucky to break blockbuster by 2025. Starting up the Boulder plant for this was stupid. I'll be surprised if AZ keeps with the same plan. And it shows. They are keeping the hiring to as low of an expense as possible. They won't move hardly any of us from the MD site due to cost. And who the hell would want to work there anyway. Way too inbred.